Related by context. All words. (Click for frequent words.) 65 diabetic kidney 63 thromboembolic disease 62 prostate carcinogenesis 62 thrombo embolic 61 antiplatelet therapies 61 impair fertility 61 induced oxidative stress 61 inflammatory bowel syndrome 61 nerve degeneration 61 intracerebral haemorrhage 60 hepatic fibrosis 60 macrovascular events 60 antioxidant supplementation 60 lowering blood glucose 60 probiotic supplementation 60 breast endometrial 60 mitochondrial decay 60 Heavy snorers 60 colorectal carcinogenesis 60 DVT PE 60 diabetic microvascular complications 60 Genetic predisposition 59 Erythropoietic therapies may 59 postoperative AF 59 dissolving blood clots 59 physiologic mechanisms 59 motor neuron degeneration 59 vitamin B1 deficiency 59 lowering triglyceride levels 59 renal toxicity 59 hepatic toxicity 59 intensive statin therapy 59 cardiometabolic disorders 59 lowering triglycerides 59 potentially modifiable 59 post surgical adhesions 59 venous thromboembolic disease 59 Vitamin D insufficiency 59 variant angina 59 kidney urologic 59 polyp recurrence 59 multifactorial disease 59 Pseudomonas aeruginosa infections 59 nonalcoholic steatohepatitis NASH 58 thyroid deficiency 58 allergic rhinitis hay fever 58 ricin intoxication 58 immunopathology 58 atopic disease 58 lupus renal disease 58 folic acid vitamin B# 58 cocoa flavonoids 58 induced hypoglycemia 58 Chronic pancreatitis 58 digestive disturbances 58 pathogenetic 58 Lowering cholesterol 58 fibrotic disease 58 genital herpes infections 58 cancerdefine 58 recurrent venous thromboembolism 58 coagulation abnormalities 58 gastrointestinal GI bleeding 58 vaso occlusive crisis 58 PCNSL 58 Thyroid disorders 58 impaired insulin secretion 58 antiphospholipid syndrome 58 hyperglycaemia 58 mTOR kinase 58 abnormal glucose metabolism 58 Dr. Bezprozvanny 58 hereditary predisposition 58 parasitemia 58 lowers triglycerides 58 Singh Manoux 58 Genetic variants 58 CaPre ™ 58 dietary interventions 58 cardioprotective effects 58 arterial calcification 58 pathophysiological mechanisms 58 pulmonary toxicity 58 Soy isoflavones 58 poststroke depression 58 Chlamydia trachomatis infection 58 ischemic complications 58 Genetic mutation 58 H. pylori eradication 58 KIF6 carriers 58 macrovascular complications 58 Oxidative damage 58 EBV infection 58 pharmacological therapies 58 sirtuin activators 57 chronic thromboembolic pulmonary 57 antibody mediated 57 thromboxane A2 57 anticarcinogenic effects 57 abnormal lipids 57 cardiotoxic effects 57 atherogenesis 57 apneic episodes 57 stratifying patients 57 antitumor effect 57 Alzheimer Disease AD 57 neurotrophic 57 type2 diabetes 57 intranasal corticosteroids 57 statins cholesterol lowering 57 prostate cancer CaP 57 premenstrual syndrome PMS 57 Candida overgrowth 57 pathophysiological processes 57 mTOR inhibition 57 cartilage degeneration 57 Genetic variations 57 selenium supplementation 57 vascular constriction 57 imatinib resistance 57 autoimmune reactions 57 inhibits blood clotting 57 antioxidant vitamin supplements 57 inhibit metastasis 57 Calcium intake 57 triglyceride lowering 57 Prognostic factors 57 insulin resistance precursor 57 periodontal infection 57 etiological 57 type 1diabetes 57 elevated IOP 57 atherosclerotic vascular disease 57 postprandial hyperglycemia 57 endometrial hyperplasia 57 underlying molecular mechanisms 57 contrast induced nephropathy 57 cardiac conduction 57 Hypoglycaemia 57 dysrhythmias 57 neurocognitive deficits 57 riociguat 57 torsade de pointes 57 lipoprotein metabolism 57 cardiovascular disease osteoporosis 57 Reye syndrome rare 57 valvular heart disease 57 Severe hypoglycemia 57 cardiovascular morbidity 57 Viral infections 57 Chronic illnesses 57 thromboembolic 57 primary hyperparathyroidism 56 ALI ARDS 56 neuroprotective agent 56 gallstone formation 56 bronchial inflammation 56 CMV infections 56 NIASPAN 56 antithrombotic therapy 56 cardiovascular thrombotic 56 serum biomarkers 56 lethal arrhythmias 56 amyloid â 56 dietary antioxidants 56 EMPOWER TM 56 Elevated CRP 56 NSAID induced 56 biologic pathways 56 thrombotic complications 56 mouthwashes containing 56 atherothrombotic 56 neovascularisation 56 neuro degeneration 56 systemic inflammation 56 airway constriction 56 carotid atherosclerosis 56 deferiprone 56 atherosclerotic coronary 56 bronchial hyperresponsiveness 56 neuroinflammatory 56 ischemic cardiovascular 56 cardiovascular disease hypertension 56 colorectal adenoma 56 atherosclerotic cardiovascular 56 arterial inflammation 56 G6PD deficiency 56 pediatric malignancies 56 myopathy rhabdomyolysis 56 adrenocortical cancer 56 bacterial respiratory infections 56 Staph aureus infections 56 sonographic diagnosis 56 thromboembolic complications 56 stiff achy joints 56 occlusive vascular 56 ischemic vascular 56 residual confounding 56 dietary modification 56 lowering homocysteine 56 antithrombotic therapies 56 Uncontrolled hypertension 56 hypoglycemic episodes 56 antiplatelet medications 56 Critical limb ischemia 56 homocysteine lowering 56 Antioxidant supplements 56 secondary hyperparathyroidism 56 Acute pancreatitis 56 presymptomatic 56 multi factorial disease 56 lipid parameters 56 metabolic disturbances 56 chemoprevention trials 56 Cholesterol lowering statins 56 iron chelators 56 Periodontal disease 56 molecular determinants 56 aetiology 56 chromium supplementation 56 prognostic indicators 56 glycosylated hemoglobin HbA1c 56 lung fibrosis 56 renal scarring 56 prognostic markers 56 leukotriene pathway 56 CP CPPS 56 chlamydial infection 56 unmeasured factors 56 gemifloxacin 56 Selenium supplements 56 Magnesium deficiency 56 microvascular disease 56 Zinc deficiency 55 prostate cancer metastasis 55 hormonally sensitive 55 CYP #A# 55 Fasting glucose 55 Bacterial infection 55 coronary blockages 55 plasminogen activators 55 candida infection 55 Warfarin Coumadin 55 GST pi 55 growth hormone secretion 55 testosterone supplementation 55 ADVEXIN therapy 55 chemopreventive agents 55 systemic toxicity 55 macrovascular disease 55 Neurological disorders 55 atherosclerosis narrowing 55 Malignant glioma 55 Vitamin B# deficiency 55 topical NSAIDs 55 thiopurine 55 venous blood clots 55 abnormal blood clotting 55 cancerous colon polyps 55 diabetic retinopathy DR 55 urate levels 55 myocardial ischaemia 55 LDL cholesterol lowering 55 nutrient supplementation 55 immunological mechanisms 55 neuronal dysfunction 55 COX inhibitors 55 upper gastrointestinal bleeding 55 microvascular complications 55 neuroinflammation 55 squamous cell lung cancer 55 bone metabolism 55 pathophysiologic mechanisms 55 Diamyd r vaccine 55 deCODE Glaucoma TM 55 vascular inflammation 55 subclinical atherosclerosis 55 pharmacogenetic tests 55 periodontal infections 55 HER2 expression 55 anti amnesic 55 postoperative pulmonary 55 EMPOWER ™ 55 ovarian hormones 55 insulin sensitizing agents 55 chlamydial 55 flavanol rich foods 55 acid suppressive therapy 55 amyloid plaque formation 55 underlying pathophysiology 55 aldosterone hormone 55 biologic plausibility 55 NSAID associated 55 platelet dysfunction 55 Lipoic acid 55 breast uterine 55 airway narrowing 55 β blockers 55 somatostatin analogs 55 gastro oesophageal reflux 55 nonalcoholic steatohepatitis 55 etiologic 55 cardio vascular diseases 55 venous thromboembolic events 55 cerebral vasospasm 55 breast cancer metastasis 55 alpha1 antitrypsin deficiency 55 Inhaled corticosteroids 55 obesity insulin resistance 55 Pelvic inflammatory 55 lowering LDL cholesterol 55 Flavanols 55 SSc 55 Iron deficiency anemia 55 EEG abnormalities 55 microangiopathy 55 pleiotropic effects 55 arterial stiffening 55 postoperative atrial fibrillation 55 Dietary calcium 55 neuro degenerative disorders 55 refractory Hodgkin 55 non pharmacological interventions 55 cardiac dysfunction 55 Darapladib 55 immune suppressive cells 55 immunotherapeutic approaches 55 Statin therapy 55 invasive candidiasis 55 Helicobacter pylori infection 55 cardiovascular ischemic 55 chronic noncommunicable diseases 55 FGFs 55 asymptomatic bacteriuria 55 diabetic gastroparesis 55 molecular abnormalities 55 macrophage migration 55 Dr. Stefanos Kales 55 plasma lipid 55 chronic rheumatic 55 treat dysmenorrhea 54 beta carotene supplementation 54 non selective NSAIDs 54 cataract formation 54 lung cancer chemoprevention 54 Elevated triglycerides 54 pathogenic mechanisms 54 blockers angiogenesis inhibitors 54 atherosclerotic disease 54 tamoxifen Nolvadex ® 54 systemic hypotension 54 prescribed proton pump 54 Vitamin D supplementation 54 gastric carcinogenesis 54 metabonomics 54 dermatologic diseases 54 teratogenicity 54 Dr. Chodick 54 Akt signaling 54 proliferative disorders 54 Listeria infections 54 tumor subtype 54 Pneumococcal pneumonia 54 cardiac repolarization 54 lipid abnormalities 54 antiangiogenic therapy 54 gastric cardia 54 glucocorticoid therapy 54 carotid plaques 54 anticoagulant warfarin 54 reperfusion injury 54 CETP inhibition 54 arterial thrombosis 54 Plasmodium falciparum malaria 54 CaM kinase II 54 liver fibrosis 54 inorganic phosphates 54 modifiable risk 54 torsades de pointes 54 severely immunosuppressed 54 pulmonary hypertension PH 54 variceal bleeding 54 Viral hepatitis 54 prognostic biomarkers 54 obstructive coronary 54 H. pylori bacteria 54 Tasigna prolongs 54 blood clotting disorders 54 reducing sodium intake 54 hepatotoxic 54 SRBD 54 glycated hemoglobin levels 54 atrial tachyarrhythmias 54 neovascular diseases 54 sideeffects 54 oxycholesterol 54 symptom flare ups 54 beta carotene supplements 54 glitazone class 54 unmeasured confounders 54 dietary acrylamide 54 genetic susceptibilities 54 COREG 54 spinal metastases 54 hepatitis B infection 54 untreated celiac disease 54 rheumatic disorders 54 nonpharmacological treatments 54 excitotoxic 54 Postmenopausal hormone therapy 54 photoaging 54 Vitamin B9 54 antipsychotic induced 54 Angiotensin converting enzyme 54 intestinal mucosal 54 ventricular remodeling 54 Avandia Actos 54 inflammatory demyelinating 54 neuroregenerative 54 intensive lipid lowering 54 spontaneous regression 54 atrial arrhythmias 54 COX enzymes 54 Dental caries 54 proliferative diabetic retinopathy 54 CV thrombotic 54 recurrent DVT 54 underdiagnosis 54 intestinal ulcers 54 chronic bilirubin encephalopathy 54 rhythm disturbances 54 Clostridium difficile infections 54 Triptans 54 endocrine dysfunction 54 Genetic variation 54 H. pylori infections 54 Calorie restriction 54 immune dysregulation 54 bronchopulmonary dysplasia BPD 54 Temporal lobe epilepsy 54 blood thinner Warfarin 54 fermentable carbohydrates 54 Mevacor OTC 54 Ischemic heart 54 atherogenic dyslipidemia 54 Diabetic nephropathy 54 trastuzumab Herceptin ® 54 axonal degeneration 54 thiazide 54 inherited predisposition 54 socioeconomic gradient 54 pulmonary inflammation 54 hyperhomocysteinemia 54 pharmacological therapy 54 dementing illnesses 54 tardive dyskinesia TD 54 immune modulating 54 Chronic inflammation 54 gastritis ulcers 54 renoprotective 54 Heavy menstrual bleeding 54 serum urate levels 54 etiological factors 54 allergen immunotherapy 54 Adequate vitamin D 54 Strenuous exercise 54 arterial plaque buildup 54 prolonged QT interval 54 iron overload 54 pancreatic carcinogenesis 54 neuro developmental disorders 54 Aggrastat ® tirofiban hydrochloride 54 nonvascular 54 coinfection 54 phenotypic expression 54 silent myocardial ischemia 54 Adenoviruses usually cause 54 inflammatory rheumatic 54 uncontrolled epilepsy 54 HIV HCV coinfected 54 olmesartan 54 hypercholesterolaemia 54 embolic stroke 54 microvascular dysfunction 54 hyperphosphatemia 54 cardio metabolic diseases 54 CYT# potent vascular disrupting 54 serum BDNF 54 hematopoietic malignancies 54 enzyme renin 54 CSF biomarkers 54 hyperinsulinism 54 Inhaled steroids 54 pathophysiologic 54 idiopathic pulmonary 54 treating peripheral arterial 54 Autoimmune diseases 54 statin medications 54 pre malignant lesions 54 clevidipine 54 atypical femur fractures 54 Factor Xa inhibitors 54 peroxidation 54 P. falciparum malaria 54 familial clustering 54 Cachexia 54 antitumor efficacy 54 CTAP# Capsules 53 cardiometabolic diseases 53 cardiometabolic risk 53 biological plausibility 53 oral RSD# 53 neurodegenerative illnesses 53 adrenal suppression 53 alkalosis 53 cardiovascular disease 53 Colon polyps 53 Haptoglobin 53 Alpha lipoic acid 53 vertebral subluxation 53 Calcium vitamin D 53 cytomegalovirus infection 53 MS relapses 53 Treg cell 53 induced cardiomyopathy 53 MYH9 53 lipid lowering therapies 53 DHEA supplementation 53 allograft rejection 53 lipohypertrophy 53 beta blockers ACE inhibitors 53 Reducing sodium intake 53 polyphenol rich 53 insulin sensitizing 53 acute GVHD 53 gastro esophageal reflux 53 lichen planus 53 prognostic indicator 53 valacyclovir Valtrex 53 recurrent miscarriage 53 ispinesib administered 53 pleiotropic 53 hypertension hypercholesterolemia 53 Venous thromboembolism 53 leukotriene receptor antagonist 53 untreated OSA 53 dietary supplementation 53 pharmacological approaches 53 bacterial antibiotic resistance 53 unmeasured confounding 53 rhinovirus infection 53 thrombotic events 53 perinatal complications 53 molecular underpinnings 53 systemic corticosteroid 53 Homocysteine 53 tissue oxygenation 53 progestin therapy 53 Ischaemic heart 53 acetylcysteine 53 Meridia sibutramine 53 Cholesterol lowering 53 leptin deficiency 53 meningitis epidemics 53 triglyceride concentrations 53 platelet clumping 53 Kinoid 53 artery stenosis 53 thetreatment 53 Dietary fats 53 carotid plaque 53 cystic fibrosis chronic pancreatitis 53 Shark cartilage 53 allogeneic HSCT 53 cobiprostone 53 impaired glucose metabolism 53 prolongs survival 53 fatal IHD 53 familial predisposition 53 pharmacologic intervention 53 Cristofanilli 53 investigational therapies 53 platelet activation 53 tissue perfusion 53 knee osteoarthritis OA 53 gastrointestinal GI cancers 53 cardioprotection 53 hemorrhagic complications 53 vitamin supplementation 53 cardiac biomarkers 53 Therein lurks 53 gonococcal 53 antiangiogenic agents 53 neuropsychiatric diseases 53 Commonly prescribed 53 myocardial fibrosis 53 levodopa induced 53 containing abacavir 53 lymph node enlargement 53 ASK DR 53 pancreas esophagus 53 BEXXAR Therapeutic Regimen 53 Angiotensin receptor blockers 53 vasodilatation 53 causative pathogens 53 gallstone disease 53 MICARDIS ® 53 osteoporosis brittle bones 53 Neurodegenerative diseases 53 Nonspecific 53 severe hypersensitivity reactions 53 neural degeneration 53 biliary obstruction 53 Peripheral artery disease 53 Parasitic worms 53 antiemetics 53 Cancer cachexia 53 aromatase inhibitors AIs 53 lipid synthesis 53 melatonin supplements 53 pelvic malignancies 53 folic acid deficiency 53 paricalcitol 53 bronchodilatory 53 Untreated sleep apnea 53 CIPN 53 membranous nephropathy 53 folic acid intake 53 CVD mortality 53 AA Amyloidosis 53 recurrent genital herpes 53 cirrhosis liver failure 53 endothelial activation 53 IntroductionThe 53 liver scarring 53 Idiopathic pulmonary fibrosis IPF 53 molecularly targeted therapies 53 endothelin antagonist 53 Rectal bleeding 53 Hedgehog inhibitor 53 Marc Weisskopf 53 folate supplementation 53 Ovary removal 53 COX2 53 validating biomarkers 53 hepatocellular carcinoma liver 53 pharmacodynamic markers 53 invasive fungal 53 chemopreventive 53 transfusion transmitted 53 blood coagulation disorders 53 hematopoietic cancers 53 metabolic abnormalities 53 perinatal morbidity 53 deCODE BreastCancer 53 inhibit CYP#A# 53 QTc intervals 53 seizures comas 53 ADME properties 53 Inhaled anthrax 53 endogenous hormones 53 surgical adhesions 53 dopaminergic therapy 53 Fatty liver 53 hypervascular tumors 53 intravascular hemolysis 53 gastric distention 53 parkinsonian symptoms 53 corticosteroid therapy 53 renal flares 53 colon carcinogenesis 53 optimal dosing 53 Pfizer respectfully disagrees 53 mGluR4 activation 53 LDL oxidation 53 Guillain Barre Syndrome GBS 53 liver metastasis 53 vessel constriction 53 activated microglia 53 insulin resistance syndrome 53 inhaled bronchodilators 53 Alzheimer pathology 53 elevated triglyceride levels 53 aerosolized KL4 surfactant 53 antioxidant intake 53 POM Juice 53 infants Sundlof 53 vidofludimus 53 overt nephropathy 53 immunosuppressive regimens 53 relieve constipation 53 mechanistic studies 53 diagnostic modality 53 developmental neurotoxicity 53 gastrointestinal absorption 53 airway hyperresponsiveness 53 elevated uric acid 53 Clot busting 53 NSAID induced GI 53 endometrial kidney 53 detoxify carcinogens 53 transfusion syndrome 53 Estrogen deficiency 53 antiresorptive 53 Cognitive impairment 53 intact parathyroid hormone 53 lomitapide 53 angiotensin receptor blockers ARBs 53 pancreatic alpha 53 mitochondrial mutations 53 biochemical abnormalities 53 exploratory endpoints 53 evaluate ZFP Therapeutic 53 tamoxifen metabolism 53 ANAVEX #-# [001] 53 neuroprotective therapies 53 glaucoma macular degeneration 53 metabolic acidosis 53 NAbs 53 optimal glycemic 53 jaw osteonecrosis 53 intestinal cramping 53 colorectal cancer CRC 53 lowers LDL cholesterol 53 precursor lesions 53 CYP#D# genotype 53 magnesium intake 53 delay bone metastases 53 oesophageal adenocarcinoma 53 Colorectal cancers 53 hypovitaminosis D 53 #beta HSD1 53 HMGCR 53 antiinflammatory drugs 53 glucose triglycerides 53 Prenatal vitamins 53 silent ischemia 53 sulfonylurea metformin 53 Randomized clinical trials 53 Premature menopause 53 hypertension diabetes mellitus 53 immune globulins 53 CVBT #H 53 vaginal yeast infections 53 glucose homeostasis 53 birth defects premature 53 APOE genotype 53 NNT = 53 anti angiogenic drugs 52 thyrotropin 52 nonischemic 52 RSV infections 52 fatty acid supplementation 52 Liver transplantation 52 heterozygous FH 52 hyperparathyroidism 52 pharmacologic treatments 52 leptin resistance 52 Peripheral arterial disease 52 chemoprotective 52 Diabetic neuropathy 52 carbohydrate polymers 52 VADT 52 Artificial pancreas 52 untreated hypothyroidism 52 detecting diagnosing 52 antiarrhythmic 52 respiratory viral infections 52 hypernatremia 52 Bergenstal 52 biphosphonates 52 airway remodeling 52 chemopreventive agent 52 dysglycemia 52 gastric irritation 52 fibrate drugs 52 cardioembolic stroke 52 immunosuppressive therapies 52 authors hypothesize 52 Calcium supplements 52 mediated inhibition 52 non cirrhotic portal 52 cyclooxygenase 2 52 ovarian cervical 52 chronic periodontitis 52 cardio vascular disease 52 choroidal vasculopathy 52 recurrent bladder 52 nongenetic 52 bile acid metabolism 52 thiazolidinedione TZD 52 Therapeutic hypothermia 52 genetic determinants 52 vivo coagulation 52 postoperative radiotherapy 52 secretory diarrhea 52 spontaneous preterm delivery 52 Genetic susceptibility 52 pharmacotherapeutic 52 da mage 52 atherothrombosis 52 Sugar sweetened beverages 52 inhibit platelet function 52 LibiGel ® 52 familial hypercholesterolemia FH 52 fatty acid oxidation 52 autoimmune cardiovascular 52 Proteinuria 52 Frequent urination 52 postoperative delirium 52 Cholinesterase inhibitors 52 abnormal lipid 52 antihypertensive therapy 52 multivitamin supplements 52 atherothrombotic disease 52 psoriatic arthritis PsA 52 topical microbicides 52 concomitant medications 52 neurological degeneration 52 hypoglycemia unawareness 52 malabsorptive 52 hippocampal atrophy 52 digestive tract cancers 52 yeast overgrowth 52 abnormal glucose tolerance 52 serum PTH 52 colorectal adenomas 52 nonhealing wounds 52 rheumatoid arthritis osteoarthritis ankylosing 52 ticagrelor Brilinta 52 bardoxolone methyl 52 alleviate menopausal symptoms 52 Sentinel node biopsy 52 debilitating neurodegenerative 52 noncardiovascular 52 protein misfolding diseases 52 GERD sufferers 52 CVT E# 52 ACAT2 52 primary aldosteronism 52 trans palmitoleic acid 52 arterial hypertension 52 lactose malabsorption 52 cholestasis 52 vasculopathy 52 diagnose coronary artery 52 recurrent pulmonary embolism 52 surrogate marker 52 Thiazolidinediones 52 latent tuberculosis TB 52 N acetyl cysteine 52 noscapine 52 multifactorial 52 nocturnal hypoglycaemia 52 IDH mutations 52 cardiometabolic syndrome 52 intestinal absorption 52 antiplatelet drugs 52 visceral adiposity 52 antidiabetic drug 52 prion infection 52 immune suppressants 52 disregulation 52 photoprotection 52 dysfunction Zada 52 fibrin deposition 52 dyslipidemias 52 ThGRF 52 overt hepatic encephalopathy HE 52 Aortic aneurysms 52 dietary DHA 52 enzyme NADPH oxidase 52 anovulatory infertility 52 epithelial barrier 52 non ulcer dyspepsia 52 immuno modulatory 52 bezafibrate 52 Hepatocellular Carcinoma HCC 52 anti dyslipidemic 52 antithrombotic agents 52 fibrotic disorders 52 antiproliferative effects 52 oral mucositis OM 52 fluid overload 52 prenatal exposures 52 enterovirus infection 52 delayed gastric emptying 52 PAOD 52 LV dysfunction 52 ischemia induced 52 intracranial stenosis 52 lowers LDL 52 Marcia Stefanick 52 hormonally responsive 52 neuropsychological impairments 52 etiologic factors 52 tumor histology 52 fat malabsorption 52 Irregular heartbeat 52 uncontrolled asthma 52 hormonal abnormalities 52 pancreas secretes insulin 52 comorbid disorders 52 atherosclerosis plaque buildup 52 biologic antibody 52 bony metastases 52 PPAR γ 52 Crohns disease 52 hypokalaemia 52 inhaled glucocorticoids 52 dyslipidaemia 52 torcetrapib atorvastatin 52 dietary sodium 52 metabolic dysfunctions 52 compulsive hoarding syndrome 52 eicosanoids 52 blindness amputation 52 platelet inhibition 52 reflux symptoms 52 Gastric cancer 52 urinary tract infections UTIs 52 antidepressive 52 gingival inflammation 52 Hypertriglyceridemia 52 metformin Glucophage 52 Hypotension 52 creatine supplementation 52 relieving constipation 52 macrovascular 52 Observational studies 52 TLR antagonists 52 KRAS status 52 Insulin detemir 52 γ secretase 52 biochemical imbalances 52 CB2 receptor 52 atherosclerosis hardening 52 Atopic dermatitis 52 cryptoxanthin 52 myopathies 52 Epidemiologic studies 52 mycosis 52 QT prolongation 52 oral anticoagulation 52 thromboembolism 52 recurrent myocardial infarction 52 elevated fasting glucose 52 thrombosis blood clots 52 Perforomist ™ Inhalation Solution 52 empiric therapy 52 androgen ablation 52 ovarian suppression 52 invading pathogen 52 Celecoxib 52 Surgical excision 52 diabetic polyneuropathy 52 STAT3 signaling 52 acute phosphate nephropathy 52 Micro RNAs 52 Clogged arteries 52 sudden coronary thrombosis 52 debilitating neurodegenerative disorder 52 POAG 52 CETP gene 52 pathophysiological 52 pharmacodynamic parameters 52 antithrombotic 52 neuro psychiatric disorders 52 Diana Schendel 52 tumor subtypes 52 CAM modalities 52 antiobesity 52 hyperphenylalaninemia HPA due 52 LDL HDL 52 dyslipidemia hypertension diabetes 52 OnDose TM 52 irregular heartbeat atrial fibrillation 52 collagen degradation 52 Relapsing remitting MS 52 cardiometabolic 52 alpha defensin 52 hyperacute 52 hematological parameters 52 mal absorption 52 modifiable cardiovascular 52 hydrolyzed formula 52 Accutane isotretinoin 52 bovine mastitis 52 HAART regimens 52 thromboprophylaxis 52 TNF alpha antagonist 52 postpartum hemorrhage 52 Chronic insomnia 52 obesity sedentary lifestyle 52 direct thrombin inhibitors 52 dosing frequency 52 abdominal abscesses 52 estrogen metabolism 52 skeletal fluorosis